SILENSOMES Trademark

Trademark Overview

On Monday, May 6, 2013, a trademark application was filed for SILENSOMES with the United States Patent and Trademark Office. The USPTO has given the SILENSOMES trademark a serial number of 79134613. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Saturday, May 6, 2023. This trademark is owned by BIOFARMA. The SILENSOMES trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:

Chemical, biological and micro-biological products for industrial use and for research use, namely industrial chemicals, biological tissue cultures other than for medical or veterinary purposes; cell microsomes for industrial use, for laboratory, medical or scientific research and evaluation of drug candidates

[ Scientific research and design of in-vitro models for studies of the metabolism of drug candidates; scientific research and design of in-vitro models for testing drug interactions; scientific research of methods used in the evaluation, research and development of new drugs ]
silensomes

General Information

Serial Number79134613
Word MarkSILENSOMES
Filing DateMonday, May 6, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSaturday, May 6, 2023
Registration Number4557982
Registration DateTuesday, July 1, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 15, 2014

Trademark Statements

Goods and ServicesChemical, biological and micro-biological products for industrial use and for research use, namely industrial chemicals, biological tissue cultures other than for medical or veterinary purposes; cell microsomes for industrial use, for laboratory, medical or scientific research and evaluation of drug candidates
Goods and Services[ Scientific research and design of in-vitro models for studies of the metabolism of drug candidates; scientific research and design of in-vitro models for testing drug interactions; scientific research of methods used in the evaluation, research and development of new drugs ]

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeH - NOT AVAILABLE
Class Status DateSaturday, May 6, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeG - NOT AVAILABLE
Class Status DateWednesday, November 4, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOFARMA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCedex F-92284
FR
Party NameBIOFARMA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameBIOFARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Sunday, November 26, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, November 26, 2023DEATH OF INTERNATIONAL REGISTRATION
Saturday, July 1, 2023COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Saturday, August 14, 2021PARTIAL INVALIDATION PROCESSED BY THE IB
Friday, July 16, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, July 16, 2021INVALIDATION PROCESSED
Sunday, July 4, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, November 4, 2020NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Wednesday, November 4, 2020REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Wednesday, November 4, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 17, 2020TEAS SECTION 71 & 15 RECEIVED
Monday, July 1, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, November 28, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 24, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 24, 2014FINAL DISPOSITION PROCESSED
Wednesday, October 1, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 1, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, April 15, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 15, 2014PUBLISHED FOR OPPOSITION
Thursday, April 10, 2014NOTIFICATION PROCESSED BY IB
Wednesday, March 26, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 26, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 26, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 11, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 10, 2014ASSIGNED TO LIE
Saturday, February 22, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 19, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 19, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 19, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 13, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 13, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 23, 2013REFUSAL PROCESSED BY IB
Wednesday, August 28, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, August 28, 2013REFUSAL PROCESSED BY MPU
Tuesday, August 27, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 27, 2013APPLICATION FILING RECEIPT MAILED
Monday, August 26, 2013NON-FINAL ACTION WRITTEN
Friday, August 23, 2013ASSIGNED TO EXAMINER
Friday, August 23, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 22, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

silensomes research scientific biological industrial drug evaluation models vitro medical candidates